#tumorImmunology
LightNews LightNews
obenaufa.bsky.social
🐦➡️🦋 Looking to rebuild your network on Bluesky by reconnecting with your existing X/Twitter contacts? The Skylink browser extension makes it easy!
chromewebstore.google.com/detail/sky-f...

Thanks @jmschreiber91.bsky.social!
#scicomm #cancer #tumorimmunology
Sky Follower Bridge - Chrome Web Store
Instantly find and follow the same users from your Twitter follows on Bluesky.
chromewebstore.google.com
November 17, 2024 at 10:56 AM
jem.org
New: Amir Ferry, Ananda Goldrath and colleagues @ucsdhealthsci.bsky.social show that differentiation of tissue-resident memory T cells (TRM) is accompanied by the upregulation of the conventional DC1 (cDC1) chemoattractant, Xcl1. https://buff.ly/4hrKCYe

#MucosalImmunology #TumorImmunology
January 22, 2025 at 5:14 PM
tenuretracker.bsky.social
Technische Universitat Munchen (@tum.de) is hiring:
PhD position in Tumor Immunology

#phd #medicine #tumorimmunology
October 2, 2026 at 3:52 PM
jem.org
Kuhn, @maxkrummel.bsky.social et al. demonstrate how local gene editing of cancer-associated fibroblasts alters their cell state and, subsequently, the cellular tumor microenvironment rupress.org/jem/article/...

#TME #CAFs #TumorImmunology
March 25, 2026 at 4:00 PM
lozanzi.bsky.social
#MustRead for #Neutrophils & #TumorImmunology lovers! @cp-immunity.bsky.social by @MelissaNg @DanielaCerezo-Wallis @LaiGuanNg & @andreshidalgo.bsky.social! www.sciencedirect.com/science/arti...
Adaptations of neutrophils in cancer
There is a renewed interest in neutrophil biology, largely instigated by their prominence in cancer. From an immunologist’s perspective, a conceptual …
www.sciencedirect.com
January 14, 2025 at 6:54 PM
jem.org
Local gene editing of #fibroblasts in tumors reveals a new cancer-associated fibroblast state. New study from Nicholas F. Kuhn, Matthew F. Krummel @maxkrummel.bsky.social @immunox.bsky.social and colleagues:
rupress.org/jem/article/...

#TumorImmunology #SolidTumors #TME #CAFs
April 1, 2026 at 7:31 PM
jem.org
Lymphatic chain gradients regulate the magnitude and heterogeneity of T cell responses to #vaccination. new study from Michael Conlon, Jessica Huang, and Michael Gerner (University of Washington): rupress.org/jem/article/...

#LymphocyteBiology #InnateImmunity #inflammation #TumorImmunology
May 7, 2025 at 7:47 PM
jem.org
Regulatory T cells converted from Th1 cells in tumors suppress #cancer immunity via CD39, say Sang-Nee Tan, Chen Dong and colleagues (Westlake University): https://buff.ly/3ED6d1G

#TumorImmunology #SolidTumors #LymphocyteBiology
February 12, 2025 at 3:14 PM
jem.org
MHC one–two punch knocks out #cancer. Amir Ghorbani and Jonathan Yewdell @niaidnews.bsky.social discuss new study by Zhang, Chamoto and colleagues @ccii-kyoto.bsky.social (rupress.org/jem/article/...) in Insights: rupress.org/jem/article/...

#TumorImmunology #Immunotherapy
January 27, 2026 at 2:30 PM
jem.org
Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection, say Benjamin Broomfield (@benjbroom.bsky.social), Joanna Groom (@groomlab.bsky.social) and colleagues: rupress.org/jem/article/...

#TumorImmunology #LymphocyteBiology #Virology #Vaccines
March 17, 2025 at 2:48 PM
jem.org
@rafaelblancodom.bsky.social, @bsilvasantos.bsky.social, Mensurado et al. @gimminstitute.bsky.social demonstrate that regulatory T cells constrain IFNγ-producing γδ T cells by competing for IL-2, thereby limiting their expansion and anti-tumor function. rupress.org/jem/article/...

#TumorImmunology
May 13, 2026 at 4:03 PM
jem.org
The 2025 𝘉𝘦𝘴𝘵 𝘰𝘧 𝘑𝘌𝘔 highlights research in basic #immunology, #immunotherapy & #TumorImmunology, #InbornErrorsOfImmunity, #neurodegeneration, & #inflammation. We remain grounded in our commitment to publishing studies that push the boundaries of our knowledge forward 👉 rupress.org/jem/collecti...
December 17, 2025 at 3:15 PM
jem.org
T cell engagers emerge as a compelling therapeutic modality. New review from Baeuerle, Grieshaber-Bouyer, Sauer, and Michaelson: rupress.org/jem/article/...

#CancerFocus #TumorImmunology #TcellEngagers
January 12, 2026 at 2:30 PM
jem.org
Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2. New study from Suin Jo, Kenneth Murphy and colleagues @washumedicine.bsky.social: https://buff.ly/42LUFDr

#TumorImmunology #DendriticCells
February 14, 2025 at 3:47 PM
jem.org
Age- and diet-instructed metabolic rewiring of the tumor–immune microenvironment. New review from Ana Belén Plata-Gómez and Ping-Chih Ho @unil.bsky.social: rupress.org/jem/article/...

#Metabolism #Cancer #TumorImmunology
April 18, 2025 at 1:52 PM
efis-immunology.bsky.social
Following the recommendation of the EFIS Gender & Diversity Task Force, #EFIS is pleased to announce that 2025 EJI Ita Askonas Prize is awarded to @obenaufa.bsky.social from the @impvienna.bsky.social!
🎉Our warm congratulations
🔗 www.efis.org/news/2025-ej...
#tumorimmunology
@eurjimmunol.bsky.social
December 17, 2025 at 9:45 AM
jem.org
@ostendorflab.org, @immushuang.bsky.social, @sohailtavazoie.bsky.social et al. show that activation of LXRs elicits a T cell "pre-effector" state that enhances priming and promotes anti-tumor immunity. rupress.org/jem/article/...

#TumorImmunology
February 10, 2026 at 5:04 PM
jem.org
CD1d remodels the tumor-infiltrating myeloid populations controlling anti-tumor immunity. New study from Lauren Evans, Maria Conde Poole, Patricia Barral @barrallab.bsky.social @kingscollegelondon.bsky.social @crick.ac.uk and colleagues:
rupress.org/jem/article/...

#BreastCancer #TumorImmunology
August 20, 2026 at 1:45 PM
jem.org
Chimeric MHC class I and II-restricted non-self epitopes broaden anti-tumor T cell reactions. New study from Rongsheng Zhang, Tasuku Honjo, Kenji Chamoto and colleagues @ccii-kyoto.bsky.social: rupress.org/jem/article/...

#TumorImmunology
December 12, 2025 at 8:15 PM
jem.org
Explore the 2025 𝘉𝘦𝘴𝘵 𝘰𝘧 𝘑𝘌𝘔 papers in basic #immunology, #immunotherapy and #TumorImmunology, #InbornErrorsOfImmunity, #neurodegeneration, and #inflammation 👉 rupress.org/jem/collecti...

THANK YOU to our authors, reviewers, and readers for your interest and continued support for JEM!
January 16, 2026 at 2:31 PM
jem.org
CD301b⁺ monocyte-derived dendritic cells mediate resistance to #radiotherapy, say Sirimuvva Tadepalli, Derek Clements, Juliana Idoyaga @idoyagalab.bsky.social and colleagues @stanfordmedicine.bsky.social @ucsdmedschool.bsky.social: rupress.org/jem/article/...

#InnateImmunity #TumorImmunology
April 3, 2025 at 6:09 PM
jem.org
The transcription factor IRF8 drives tumor-specific exhaustion in CD8⁺ T Cells. New study from Marco Ongaro, Grégory Verdeil and colleagues @fbm-unil.bsky.social @ludwigcancer.bsky.social: rupress.org/jem/article/...

#TumorImmunology #Immunotherapy
June 29, 2026 at 1:45 PM
immunegirl.bsky.social
I’m excited to be a co-organizer this year for the SITC Winter School, where we focus on the core principles of #TumorImmunology & #CancerImmunotherapy. We’ll also be discussing advancements in drug development, biomarkers, & clinical trials. More info here: go.sitcancer.org/3XOCoBh Please join us!
December 23, 2024 at 4:10 PM
jem.org
Perturbation of Calreticulin potentiates CD8⁺ T cell-mediated anti-tumor immunity, say Kaiyang Tang, Lijian Wu, Zexian Zeng @pku1898.bsky.social, Deng Pan @tsinghuauniversity.bsky.social and colleagues: rupress.org/jem/article/...

#TumorImmunology #Immunotherapy
August 27, 2025 at 2:45 PM